AMOXICILLIN Tablets recalled over manufacturing violations
- Recall date
- January 26, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- CARDINAL HEALTHCARE recalls AMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540.…
- Recall number
- D-0166-2024
- FDA classification
- Class II
- Brand / firm
- CARDINAL HEALTHCARE
- Sold / distributed
- Nationwide USA
Why it was recalled
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
AMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540. NDC: 0781-5060-20
Get recall alerts
Free email alert whenever CARDINAL HEALTHCARE has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: CARDINAL HEALTHCARE